Biohaven Pharmaceutical

Developer of therapies targeting neurological and neuropsychiatric diseases

placeNew Haven, Connecticut, United States calendar_todayFounded 2014 groups932 employees language biohavenpharma.com

Registered entities

Investor mix

14 investors on record; lead investors include Venrock; 2 have since exited.

Investor typeCountShare
Venture capital857%
Private equity321%
Other / undisclosed321%
Coming soon